Literature DB >> 35112562

SARS-CoV-2 infection in adults and HIV: an update.

Dimitrios Bousis1, Francesk Mulita2, Ioanna Marlafeka1, Themistoklis Paraskevas1, Dimitrios Velissaris1.   

Abstract

Aim COVID-19 pandemic caused by SARS-CoV-2 is spreading throughout the world affecting both healthy individuals and people with underlying immune-deficiencies. People living with human immunodeficiency virus (HIV) consist a group multiply affected by this universal crisis. Methods Literature search aiming to identify relevant publications referring to the consequences of the COVID-19 pandemic in HIV infected population. Results A body of literature is rapidly growing in regard to epidemiological data, the interaction between HIV and SARS-CoV-2, and clinical outcome in people living with HIV. Intensive research is warranted to identify any interactions of the co-existence of the two viruses in the immune system of HIV infected patients as common pathophysiology and molecular aspects are recognized. Human relations are diminished as a result of the social measures, and detailed recording of the consequences in this population is needed. Conclusion Further research could shed light on the common underlying molecular mechanisms of both conditions in an attempt to discover treatment regimens for SARS-CoV-2 infection. Copyright© by the Medical Assotiation of Zenica-Doboj Canton.

Entities:  

Keywords:  AIDS; COVID-19; pandemic

Mesh:

Year:  2022        PMID: 35112562     DOI: 10.17392/1440-21

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  1 in total

1.  A challenging case of pneumothorax in a COVID-19 pneumonia patient. Can fresh frozen plasma pleurodesis be an effective treatment?

Authors:  Konstantinos Skevis; Georgios-Ioannis Verras; Francesk Mulita; Aikaterini Volonaki; Ioannis Dimitriou; Nikolaos Christodoulou; Ioannis Panagiotopoulos; Levan Tchabashvili; Dimitrios Filis; Efstratios Koletsis
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.